Skip to main content


Biosimilars

Featured

News
A recent article outlines challenges that remain regarding the regulatory evaluation of biosimilars and offers potential solutions for the future.
News
A recent policy review identifies factors that prevent the effective launch of oncology biosimilars.
News
Biosimilar rituximab and biosimilar trastuzumab are associated with acceptable safety profiles among patients with…
News
A position paper released by the American College of Physicians made concrete policy reform suggestions for…
Quiz
True or False: Chemotherapy-induced febrile neutropenia prophylaxis with biosimilar pegfilgrastim-bmez increases the…
Back to Top